期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Genetic evaluation of twenty seed sources of Asparagus racemosus
1
作者 Parveen a kumar H. S. Ginwal 《Journal of Forestry Research》 SCIE CAS CSCD 2011年第1期39-42,共4页
A field trial of 20 seed sources of Asparagus racemosus was conducted at the Forest Research Institute, Dehradun, Uttarakhand, India to evaluate their performance of different economic traits. Genotypic variance, phen... A field trial of 20 seed sources of Asparagus racemosus was conducted at the Forest Research Institute, Dehradun, Uttarakhand, India to evaluate their performance of different economic traits. Genotypic variance, phenotypic variance, genotypic coefficient of variance (GCV) and phenotypic coefficient of variance (PCV) for number of shoots, shoot height, shoot weight, number of roots, root length, root diameter and root weight were calculated. Maximum genotypic and phenotypic variance was observed in shoot height among the shoot - related traits and root length among the root - related traits. For the shoot height, genotypic variance, phenotypic variance, genotypic coefficient of variance, phenotypic coefficient of variance were 231.80, 3924.80, 61.26 and 1037.32, respectively, where those of the root length were 9.55, 16.80, 23.46 and 41.27, respectively. The maximum genetic advance and genetic gain were obtained for shoot height among the shoot-related traits and root length among the root-related traits. Index values were developed for all the seed sources based on the four most important traits, and Panthnagar (Uttrakhand), Jodhpur (Rajasthan), Dehradun (Uttarakhand), Chandigarh (Punjab), Jammu (Jammu and Kashmir) and Solan (Himachal Pradesh), were promising seed sources for root production. 展开更多
关键词 Asparagus racemosus genetic advance genetic gain HERITABILITY index selection seed sources
在线阅读 下载PDF
慎用血管紧张素转换酶抑制剂 在理论上对单侧肾动脉狭窄病人有危险
2
作者 a kumar M asim +1 位作者 a M Davison 周福德 《英国医学杂志中文版》 1998年第3期106-107,共2页
血管紧张素转换酶抑制剂(ACEI)革新了充血性心力衰竭、高血压和糖尿病肾病的治疗。在心肌梗塞后,给予 ACEI 治疗可以降低致死性左心衰竭的发生率,以及提高病人的生存率。然而,尽管ACEI 好象是治疗血管疾病的良药,但是,对于无症状性动脉... 血管紧张素转换酶抑制剂(ACEI)革新了充血性心力衰竭、高血压和糖尿病肾病的治疗。在心肌梗塞后,给予 ACEI 治疗可以降低致死性左心衰竭的发生率,以及提高病人的生存率。然而,尽管ACEI 好象是治疗血管疾病的良药,但是,对于无症状性动脉硬化性肾动脉狭窄病人应用 ACEI 药物则可发生危险,且其危害将日益加重。传统观点认为:如果病人在接受 ACEI 展开更多
关键词 动脉狭窄 单侧肾 左心衰竭 充血性心力衰竭 无症状性 缺血性肾病 血管疾病 肾功能损害 糖尿病肾病 双侧肾
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部